Device Trial Radar · NCT05610787
EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
40
Planned (sponsor's estimate)
Start
Nov 14, 2022
Primary completion
Nov 10, 2023
Study completion Jan 2027
Sponsor
- Lead sponsor
- Berlin Heart, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 9, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Driving System while being used with the approved EXCOR Pediatric Ventricular Assist Device. EXCOR Active Driving System is intended for use with the approved EXCOR Pediatric VAD. The EXCOR Pediatric VAD is intended to provide mechanical circulatory support as a bridge to cardiac transplantation for pediatric patients. Pediatric candidates with severe isolated left ventricular or biventricular dysfunction who are candidates for cardiac transplant and require circulatory support may be treated using the EXCOR Pediatric. EXCOR Active is intended for use in a clinical setting. EXCOR Active can be used in any kind of hospital unit (e.g. OR, ICU, intermediate care unit or general care unit). The driving unit may be moved between clinical units using the caddy or baby buggy; however, a patient must always be accompanied by a person trained in the use of the manual pump and emergency procedures during transport in the event of an emergency. The driving unit can be transported during operation.
Conditions
- Heart Failure
- Transplant; Failure, Heart
- Congenital Heart Disease
Interventions
EXCOR Active Driving System for Pediatric VADDevice
The EXCOR Active Driving System - will be used with the EXCOR Pediatric VAD.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Device Malfunction adverse eventsTime frame: Up to 90 days
- Patient OutcomeTime frame: Up to 90 days
- Serious Adverse EventsTime frame: Up to 90 days
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Children's Hospital of Los Angeles
Los Angeles, California
Lucile Packard Children's Hospital-Stanford
Palo Alto, California
Children's Hospital Colorado
Aurora, Colorado
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.